MEDICON, INC.

Basic Information

18 Blueberry Ridge Rd
Setauket, NY, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 616767807
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. MDC-1231 for cancer prevention

    Amount: $1,803,865.00

    DESCRIPTION (provided by applicant): The chemoprevention of colon cancer has been hampered by either weak agents or significant side effects. It was recently shown that the combination of sulindac wi ...

    STTR Phase II 2012 Department of Health and Human Services
  2. An agent for the treatment of lung cancer

    Amount: $299,999.00

    DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer deaths in the US and worldwide. Given its prevalence, morbidity and mortality, it is clear that in terms of treatment, ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Not Available

    Amount: $199,899.00

    We propose studies for the preclinical development of BJ-813, a novel agent against breast cancer. BJ-813 has significant activity in vitro (human breast cancer cell lines covering the clinical spectr ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. MDC-1231 for cancer prevention

    Amount: $187,534.00

    DESCRIPTION (provided by applicant): Strong evidence supports the notion that chemoprevention has the potential to be a major component of colorectal cancer control. The prevention of cancer depends h ...

    STTR Phase I 2010 Department of Health and Human Services
  5. Novel Urea Breath Test for H. Pylori Diagnosis

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): We propose to develop a novel method for the diagnosis of Helicobacter pylori. The diagnosis of H. pylori infection is a high medical priority because: this bacter ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government